Using a ‘virtual pharma model’ to attract targeted investors for biotech innovators

Welcome to Medicon Valley Alliance Good Morning Meeting with Syneos Health on:

De-risk investment, de-risk operational delivery and maximize the return on investment (ROI) for all parties

How to position your organization for fundraising using a virtual pharma partner model – Using the ‘two heads are better than one’ approach to investor outreach, coupled with support for clinical and commercial strategy, the integration of commercial thinking into your late phase clinical plans, and a robust use of funds built from the ground up using actual budgets is an attractive proposition for investors.

We will discuss our Capital Solutions approach with case studies, and we will also hear the perspective of an investor in the space to this approach.

Read more here.